COEP · NASDAQ · Software - Services

Coeptis Therapeutics (COEP)

Nasdaq-listed Coeptis developed cell therapy assets before its Z Squared merger.

$10.99
At close−1.03 (−8.57%)

Something off on this page? Send us feedback.

EPSReportedEstimate

Aug '24Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26
Reported−$0.08−$0.05−$1.01−$1.11−$1.17−$0.58−$0.12−$1.11
Estimate−$0.09−$0.05−$0.80−$0.80
Surprise+11.1%0.0%−26.5%+85.0%

RevenueReportedEstimate

Aug '24Nov '24Mar '25May '25Aug '25Nov '25Mar '26May '26
Reported$1.9M$62.9K$200.7K$237.4K$862.0K$113.8K
Estimate
Surprise

History

DateEstimateReportedSurprise
May 2026−$1.11
Mar 2026−$0.80−$0.12+85.0%
Nov 2025−$0.58
Aug 2025−$1.17

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Mar 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Nov 2022
Aug 2022
May 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Jan 2021
Nov 2020
Jun 2020
Mar 2020
Dec 2005
Sep 2005
Jun 2005
Mar 2005
Sep 2004
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
May 14, 2026−$1.11$113.8K
Mar 19, 2026−$0.80−$0.12+85.0%$862.0K0.0%
Nov 13, 2025−$0.58$237.4K+2.9%
Aug 14, 2025−$1.17$200.7K+21.7%

The latest year is open to everyone — the 26 quarters behind it read with an account.

Sign in
May 14, 2025
Mar 28, 2025
Nov 13, 2024
Aug 16, 2024
May 10, 2024
Mar 26, 2024
Nov 9, 2023
Aug 11, 2023
May 15, 2023
Mar 29, 2023
Nov 18, 2022
Aug 2, 2022
May 12, 2022
Mar 11, 2022
Nov 15, 2021
Aug 16, 2021
May 18, 2021
Jan 11, 2021
Nov 23, 2020
Jun 30, 2020
Mar 31, 2020
Dec 31, 2005
Sep 30, 2005
Jun 30, 2005
Mar 31, 2005
Sep 30, 2004